Choose a country and language

For all other countries, please click here.

The nerve to expect more. The nerve to reimagine your patients' potential.

Empower your patients with drug-resistant epilepsy to live fuller lives and achieve their full potential.

VNS Therapy patients sitting on grass

 

Empower your patients with drug-resistant epilepsy to live fuller lives and achieve their full potential

Resources & Support

Resources & Support

Discover the resources you need to make the most of VNS Therapy, including product training, expert healthcare provider perspectives, practice support, and patient education

Learn More

VNS Therapy for Pediatric Patients

VNS Therapy® for Pediatric Patients

Examine the efficacy, safety, and quality of life benefits VNS Therapy can offer your pediatric patients with drug-resistant epilepsy

Learn More

VNS Therapy for Adult Patients

VNS Therapy® for Adult Patients

Explore the benefits VNS Therapy can offer your adult patients with drug-resistant epilepsy, including improvements in seizure control and quality of life

Learn More

Real-Life Stories

Real-Life Stories

Watch real-life testimonials about how VNS Therapy has provided life-changing seizure control for adult and pediatric patients with drug-resistant epilepsy

Learn More

The nerve to move beyond medication.

When managing drug-resistant epilepsy (DRE), medications alone won’t be enough to help your patients achieve seizure control or provide improved quality of life. As soon as you suspect DRE, consider non-drug treatment options and speak to your patients about them. The sooner you act, the more likely you are to mitigate the serious consequences of DRE.

Understanding the treatment goals for DRE

Goals for patients with DRE include1:

Improving long-term seizure control

Improving long-term seizure control

  • Fewer, shorter, less severe seizures
  • Improved postictal recovery

Minimizing treatment-related side effects

Minimizing treatment-related side effects

Ensuring treatment adherence

Ensuring treatment adherence

Maximizing quality of life

Maximizing quality of life

Effective management of DRE requires a proactive treatment strategy

VNS Therapy® is the most proven neromodulation therapy in use for DRE patients and has been shown to offer quality-of-life benefits that can help patients overcome obstacles they face in everyday life. 

VNS Therapy stimulates the vagus nerve, sending mild electrical pulses to the brain to help prevent seizures

VNS Therapy stimulates the vagus nerve, sending mild electrical pulses to the brain to help prevent seizures2

Uses an implantable generator and lead and can be programmed to fit the needs of a patient's individualized treatment strategy

Uses an implantable generator and lead and can be programmed to fit the needs of each patient2

Unlike invasive brain surgeries, VNS Therapy involves a short outpatient procedure that usually takes 1 to 2 hours

Unlike invasive brain surgeries, VNS Therapy involves a short outpatient procedure that usually takes 1 to 2 hours2

Treatment is delivered automatically, maximising adherence for optimal seizure control

Treatment is delivered automatically, maximizing adherence for optimal seizure control2

VNS Therapy® controls seizures in three ways

Normal Mode

Preventative

Normal Mode

Helps prevent seizures by delivering treatment at regular intervals all day, every day2

Responsive mode (Austostim)

Responsive

AutoStim Mode*

Helps stop or shorten a seizure by responding to a rapid increase in heart rate, a proven seizure biomarker2-4

*Only available in models 106 and 1000

Magnet Mode (On-Demand)

On-Demand

Magnet Mode

Helps stop or shorten a seizure once it starts by passing the included VNS Therapy Magnet over the generator2

Responsive VNS Therapy® in action

The nerve to trust 25 years of real-world experience

VNS Therapy® is built on a legacy that spans over 2 decades. With over 1 million patient-years of treatment experience, it’s easy to see why so many physicians choose to treat DRE with VNS Therapy.

prescribed device for treating DRE<sup>4</sup>

prescribed device for treating DRE5

Only DRE neurostimulation therapy indicated to treat children as young as 4 years old

Only DRE neurostimulation therapy indicated to treat children as young as 4 years old2

125,000+ patients treated, including 35,000 children<sup>4</sup>

125,000+ patients treated, including 35,000 children5

75% of patients chose to replace their device at the end of service5

Explore VNS Therapy for adult patients

Explore VNS Therapy® for adult patients

View
Examine VNS Therapy for pediatric patients

Examine VNS Therapy® for pediatric patients

View
Learn more at a VNS Therapy webinar

Learn more at a VNS Therapy® webinar

View

Learn about our SenTiva device

View
Access product support

Access Product Support

View

References: 1. Boon P, Ryvlin P, Wheless JW, et al. European Neurological Review. 2015;10(2):171-175. 2. VNS Therapy System® Epilepsy Physician’s Manual (US), May 2020, LivaNova USA, Inc. Houston, TX. 3. Fisher RS, Afra P, Macken M, et al. Neuromodulation. 2016;19:188-195. 4. Hirsch M, Altenmüller DM, Schulze-Bonhage A. Epilepsia. 2015;56(10):1639-1647. 5. Data on file, LivaNova, Inc., Houston, TX.